University of Nevada, Las Vegas
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Nevada, Las Vegas sits in the top decile of US sponsors by registered trial count (#363 of 15,742 sponsors by registered trial count).
University of Nevada, Las Vegas: 52 sponsored US clinical trials, 17 recruiting.
University of Nevada, Las Vegas sponsors 52 registered US clinical trials on ClinicalTrials.gov, 17 of them currently recruiting, and 31 completed. 2 of these trials are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Inflammation Biomarkers, with 3 trials.
Top-decile sponsor footprint
University of Nevada, Las Vegas ranks in the top decile of sponsors by registered trial count (#363 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
31 of 33 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (93.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
52 total, page 2 of 2
Cervical Spine Manipulation Affects on Balance and Proprioception
NCT01745705
Development of a Clinical Prediction Rulefor Neck Manipulation
NCT01620905
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 1 |
| Phase 4 | 2 |
What is open in the University of Nevada, Las Vegas pipeline
17 recruiting of 52 indexed (33% open); 31 completed (60%).
Phase mix: 2 late (III/IV) vs 4 early (I/II) (early-phase heavy).
Top condition: Inflammation Biomarkers (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Nevada, Las Vegas: open-pipeline peers nationwide
Peers matched on 52 registered trials and 33% open enrollment, not the therapeutic-area sidebar.
University of Nevada, Las Vegas sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 52 trials (± recruiting share)
- Albany Medical College · 52 trials · 13% recruiting
- Burzynski Research Institute · 52 trials · 0% recruiting
- Dr. Reddy's Laboratories Limited · 52 trials · 0% recruiting
- PTC Therapeutics · 52 trials · 2% recruiting
Sponsors near 33% open enrollment (± trial volume)
- Kessler Foundation · 33% recruiting · 104 trials
- Aadi Bioscience · 33% recruiting · 9 trials
- Aaron Cook · 33% recruiting · 3 trials
- Abivax S.A. · 33% recruiting · 6 trials
Related
What to do with this University of Nevada, Las Vegas page
52 registered trials is a research-attention snapshot, not an endorsement of University of Nevada, Las Vegas or any single study.
- 17 of University of Nevada, Las Vegas's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Inflammation Biomarkers is the condition University of Nevada, Las Vegas studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Inflammation Biomarkers trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Nevada, Las Vegas pipeline card: 52 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.